Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Oct;58(4):423–431. doi: 10.1038/bjc.1988.234

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

G D Wilson 1, N J McNally 1, S Dische 1, M I Saunders 1, C Des Rochers 1, A A Lewis 1, M H Bennett 1
PMCID: PMC2246793  PMID: 3207597

Abstract

The proliferative potential of human solid tumours, in vivo, was investigated using bromodeoxyuridine (BrdUrd) incorporation and flow cytometry (FCM). Patients with solid tumours from a variety of sites were injected with 500 mg BrdUrd, intravenously, several hours prior to biopsy or surgical excision. The labelling index (LI), duration of S-phase (Ts) and thus the potential doubling time (Tpot) could be measured within 24 h of sampling. The results show that both the LI and Ts vary greatly between tumours (Ts ranges from 5.8 to 30.7 h). However, within this study of 26 evaluable patients, tumours of the same tissue origin tended to have similar Ts values. Melanomas had the shortest Ts (8.8 h), nine patients with head and neck cancer had Ts values ranging from 5.8 to 18.8 h (median 12.5 h). The longest Ts values (24 h) were found in lung and rectum. The estimates of Tpot ranged from only 3.2 days in an oat cell carcinoma to 23.2 days in a lymphoma. The striking feature of the study was that 38% of the tumours had a potential doubling time of 5 days or less. We found no relationship between proliferation and histopathological differentiation or DNA ploidy. It should now be possible to assess the prognostic significance of pretreatment cell kinetic measurements which may, in the future, aid in the selection of treatment schedules for the individual patient.

Full text

PDF
423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  2. Bresciani F., Paoluzi R., Benassi M., Nervi C., Casale C., Ziparo E. Cell kinetics and growth of squamous cell carcinomas in man. Cancer Res. 1974 Sep;34(9):2405–2415. [PubMed] [Google Scholar]
  3. Camplejohn R. S., Bone G., Aherne W. Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic study. Eur J Cancer. 1973 Aug;9(8):577–581. doi: 10.1016/0014-2964(73)90148-5. [DOI] [PubMed] [Google Scholar]
  4. Chaplin D. J., Olive P. L., Durand R. E. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res. 1987 Jan 15;47(2):597–601. [PubMed] [Google Scholar]
  5. Chavaudra N., Richard J. M., Malaise E. P. Labelling index of human squamous cell carcinomas. Comparison of in vivo and in vitro labelling methods. Cell Tissue Kinet. 1979 Mar;12(2):145–152. doi: 10.1111/j.1365-2184.1979.tb00121.x. [DOI] [PubMed] [Google Scholar]
  6. Dolbeare F., Gratzner H., Pallavicini M. G., Gray J. W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5573–5577. doi: 10.1073/pnas.80.18.5573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fowler J. F. Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):641–645. doi: 10.1016/0360-3016(86)90074-x. [DOI] [PubMed] [Google Scholar]
  8. Frindel E., Malaise E., Tubiana M. Cell proliferation kinetics in five human solid tumors. Cancer. 1968 Sep;22(3):611–620. doi: 10.1002/1097-0142(196809)22:3<611::aid-cncr2820220317>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Gratzner H. G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science. 1982 Oct 29;218(4571):474–475. doi: 10.1126/science.7123245. [DOI] [PubMed] [Google Scholar]
  10. Maciejewski B., Preuss-Bayer G., Trott K. R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 1983 Mar;9(3):321–328. doi: 10.1016/0360-3016(83)90290-0. [DOI] [PubMed] [Google Scholar]
  11. Meyer J. S. Cell kinetic measurements of human tumors. Hum Pathol. 1982 Oct;13(10):874–877. doi: 10.1016/s0046-8177(82)80045-2. [DOI] [PubMed] [Google Scholar]
  12. Meyer J. S., Donaldson R. C. Growth kinetics of squamous cell carcinoma in man. A study of four squamous cell carcinomas using stathmokinetic effect of vinblastine in vivo. Arch Pathol. 1969 May;87(5):479–490. [PubMed] [Google Scholar]
  13. Parsons J. T., Bova F. J., Million R. R. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1980 Dec;6(12):1645–1652. doi: 10.1016/0360-3016(80)90246-1. [DOI] [PubMed] [Google Scholar]
  14. Peckham M. J., Steel G. G. Cell kinetics in reticulum cell sarcoma. Cancer. 1972 Jun;29(6):1724–1728. doi: 10.1002/1097-0142(197206)29:6<1724::aid-cncr2820290642>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  15. Sakuma J. Cell kinetics of human squamous cell carcinomas in the oral cavity. Bull Tokyo Med Dent Univ. 1980 Mar;27(1):43–54. [PubMed] [Google Scholar]
  16. Saunders M. I., Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol. 1986 May;59(701):523–525. doi: 10.1259/0007-1285-59-701-523. [DOI] [PubMed] [Google Scholar]
  17. Schutte B., Reynders M. M., van Assche C. L., Hupperets P. S., Bosman F. T., Blijham G. H. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry. 1987 Jul;8(4):372–376. doi: 10.1002/cyto.990080405. [DOI] [PubMed] [Google Scholar]
  18. Shirakawa S., Luce J. K., Tannock I., Frei E., 3rd Cell proliferation in human melanoma. J Clin Invest. 1970 Jun;49(6):1188–1199. doi: 10.1172/JCI106333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Terz J. J., Curutchet H. P., Lawrence W., Jr Analysis of the cell kinetics of human solid tumors. Cancer. 1971 Nov;28(5):1100–1110. doi: 10.1002/1097-0142(1971)28:5<1100::aid-cncr2820280503>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  20. Thames H. D., Jr, Peters L. J., Withers H. R., Fletcher G. H. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):127–138. doi: 10.1016/0360-3016(83)90089-5. [DOI] [PubMed] [Google Scholar]
  21. Trott K. R., Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol. 1985 Jan;3(1):1–9. doi: 10.1016/s0167-8140(85)80002-5. [DOI] [PubMed] [Google Scholar]
  22. Wagner H. P., Käser H. Cell proliferation in neuroblastoma. Eur J Cancer. 1970 Oct;6(5):369–372. doi: 10.1016/0014-2964(70)90034-4. [DOI] [PubMed] [Google Scholar]
  23. Weiss W. The mitotic index in bronchogenic carcinoma. Am Rev Respir Dis. 1971 Oct;104(4):536–543. doi: 10.1164/arrd.1971.104.4.536. [DOI] [PubMed] [Google Scholar]
  24. White R. A., Meistrich M. L. A comment on "A method to measure the duration of DNA synthesis and the potential doubling time from a single sample". Cytometry. 1986 Sep;7(5):486–490. doi: 10.1002/cyto.990070516. [DOI] [PubMed] [Google Scholar]
  25. Wilson G. D., McNally N. J., Dische S., Bennett M. H. Cell proliferation in human tumours measured by in-vivo labelling with bromodeoxyuridine. Br J Radiol. 1988 May;61(725):419–422. doi: 10.1259/0007-1285-61-725-419. [DOI] [PubMed] [Google Scholar]
  26. Wilson G. D., McNally N. J., Dunphy E., Kärcher H., Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry. 1985 Nov;6(6):641–647. doi: 10.1002/cyto.990060621. [DOI] [PubMed] [Google Scholar]
  27. Wilson G. D., Soranson J. A., Lewis A. A. Cell kinetics of mouse kidney using bromodeoxyuridine incorporation and flow cytometry: preparation and staining. Cell Tissue Kinet. 1987 Mar;20(2):125–133. doi: 10.1111/j.1365-2184.1987.tb01091.x. [DOI] [PubMed] [Google Scholar]
  28. Young R. C., DeVita V. T. Cell cycle characteristics of human solid tumors in vivo. Cell Tissue Kinet. 1970 Jul;3(3):285–290. doi: 10.1111/j.1365-2184.1970.tb00273.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES